Netskope heads into its September 2 earnings print with analysts raising targets, shorts pulling back sharply from last month's peak, and options traders leaning noticeably more bullish than usual.
The most striking development this week is the analyst activity. Multiple firms lifted price targets in rapid succession. Oppenheimer raised its target to $19 from $16 on August 19, maintaining Outperform. Wells Fargo moved to $17 from $13 on August 17, also keeping Overweight. RBC Capital went to $18 from $13 last week. The pattern is coordinated upward revision rather than isolated optimism — and at a stock trading around $15.37, the consensus target of $17.17 implies roughly 12% headroom from here. The 11 buys against 2 holds tells the same story: the Street is broadly constructive, with little dissent on direction.
The positioning picture reinforces that read, though with some nuance. Short interest has risen about 17% over the past week to roughly 12.4 million shares — but that number needs context. Back in late July, shorts held more than 28 million shares. The current level is less than half that peak, meaning the week-on-week increase is a modest rebound off a multi-month low rather than a new wave of conviction. Borrowing costs confirm the lack of pressure: cost to borrow has fallen 20% on the week to just 0.47%, a low rarely seen in the stock's recent history. Availability is loose at nearly 300% — there are roughly three shares available to borrow for every one already lent out. The short-score reading of 50.6 is firmly mid-range and has drifted down from 62.6 on August 7, when shorts were more active. Overall, the lending market is telling a relaxed story, not a crowded one.
Options traders are the most clearly positioned group here. The put/call ratio has dropped to 0.41, well below its 20-day average of 0.46 and running about 1.5 standard deviations below the mean — the most call-heavy skew of the past year (the 52-week low in PCR was 0.18, so there's room to go further, but current levels are already meaningful). The drift lower in the PCR has been consistent over the past three weeks, coinciding almost exactly with the period when analysts started revising targets upward. Call buyers and analysts are moving in the same direction.
The institutional holder list adds useful texture. ICONIQ Capital, the largest disclosed holder at 16.6% of shares, was actively buying in early July — adding over 900,000 shares across multiple transactions — even as the stock traded in the $11-12 range. That's roughly a 25% discount to current levels. On the other side, Lightspeed Venture Partners sold into the same window. CEO Sanjay Beri's July 1 sale of $6.1 million in stock was offset by a simultaneous award of over 1 million shares, a structure that looks more like routine compensation mechanics than a directional signal. Net insider activity over the 90-day window is positive at $35.2 million, largely reflecting ICONIQ's purchases rather than management buying.
The bull case rests on 60% year-on-year net new ARR growth and Netskope's positioning as a pure-play SASE vendor with more than 4,000 enterprise customers. The bear case centres on margin pressure from larger rivals — Palo Alto, Zscaler, and others — and uncertainty following the CFO's announced retirement. The stock is up 13% over the past month, while close peers had a rougher week: CRWD fell 4% and RPD dropped nearly 6%, making Netskope's relative flatness on the week look like quiet outperformance rather than stagnation. Post-earnings reactions have been volatile — the two most recent prints produced day-one declines of 2.5% and 3.2% followed by divergent five-day outcomes, including one 17% drop after the June print. The September 2 report is the next moment that will test whether the analyst upgrades and call-buying are getting ahead of the fundamental story.
See the live data behind this article on ORTEX.
Open NTSK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
